dc.contributor.author |
Tőkés, Tímea |
|
dc.contributor.author |
Torgyik, László |
|
dc.contributor.author |
Szentmártoni, Gyöngyvér |
|
dc.contributor.author |
Somlai K |
|
dc.contributor.author |
Tóth, Andrea |
|
dc.contributor.author |
Kulka, Janina |
|
dc.contributor.author |
Dank, Magdolna |
|
dc.date.accessioned |
2016-09-21T06:31:28Z |
|
dc.date.available |
2016-09-21T06:31:28Z |
|
dc.date.issued |
2015 |
|
dc.identifier |
84928588354 |
|
dc.identifier.citation |
pagination=695-703;
journalVolume=98;
journalIssueNumber=6;
journalTitle=PATIENT EDUCATION AND COUNSELING; |
|
dc.identifier.uri |
http://repo.lib.semmelweis.hu//handle/123456789/3509 |
|
dc.identifier.uri |
doi:10.1016/j.pec.2015.02.012 |
|
dc.description.abstract |
OBJECTIVE: Primary systemic therapy (PST) followed by surgery is the standard initial treatment for locally advanced breast cancer (LABC). However, some patients are averse to mastectomy or breast-conserving surgery and do not consent to these procedures. The reasons for this controversial decision, the factors influencing the decision-making and optimal solutions for decision aiding need to be investigated. METHODS: We addressed these questions by a review of literature on the possibilities associated with different patient choices and subsequent treatment options in relation to LABC. RESULTS: A total of 5 reviews and 22 clinical studies were summarized in relation to decision making and the most successful decision aids. A discussion is given of the issues of those few patients who cannot be convinced to undergo surgery. CONCLUSION: Currently there is no guideline for the treatment of patients who reject the surgical procedures after PST. Medical oncologists should be able to apply decision aid modalities in a personalized manner to give all needed information to their patients thereby ensuring a deliberate decision-making process, facilitating acceptance of a need for surgery, and thus improving the chances of prolonged survival. PRACTICE IMPLICATIONS: Currently multidisciplinary tumor boards are the most suitable decision aids in oncological practice. |
|
dc.relation.ispartof |
urn:issn:0738-3991 |
|
dc.title |
Primary systemic therapy for breast cancer: Does the patient's involvement in decision-making create a new future? |
|
dc.type |
Journal Article |
|
dc.date.updated |
2016-06-09T12:39:01Z |
|
dc.language.rfc3066 |
en |
|
dc.identifier.mtmt |
2871858 |
|
dc.identifier.wos |
000355022700003 |
|
dc.identifier.pubmed |
25749023 |
|
dc.contributor.department |
SE/AOK/I/II. Sz. Patológiai Intézet |
|
dc.contributor.department |
SE/AOK/K/I. Sz. Belgyógyászati Klinika |
|
dc.contributor.institution |
Semmelweis Egyetem |
|